Diisobutyl phthalate

Source: Wikipedia, the free encyclopedia.
Diisobutyl phthalate
Names
Preferred IUPAC name
Bis(2-methylpropyl) benzene-1,2-dicarboxylate
Other names
Diisobutyl phthalate
Di-iso-butyl phthalate
Di(i-butyl)phthalate
Diisobutyl ester of phthalic acid
1,2-benzenedicarboxylic acid
Bis(2-methylpropyl)ester
Di(isobutyl) 1,2-benzenedicarboxylate
Isobutyl-O-phthalate
DIBP
DiBP
Palatinol IC
Identifiers
3D model (
JSmol
)
ChEBI
ChemSpider
ECHA InfoCard
 100.001.412 Edit this at Wikidata
EC Number
  • 201-553-2
KEGG
RTECS number
  • TI1225000
UNII
  • InChI=1S/C16H22O4/c1-11(2)9-19-15(17)13-7-5-6-8-14(13)16(18)20-10-12(3)4/h5-8,11-12H,9-10H2,1-4H3 checkY
    Key: MGWAVDBGNNKXQV-UHFFFAOYSA-N checkY
  • InChI=1/C16H22O4/c1-11(2)9-19-15(17)13-7-5-6-8-14(13)16(18)20-10-12(3)4/h5-8,11-12H,9-10H2,1-4H3
    Key: MGWAVDBGNNKXQV-UHFFFAOYAA
  • O=C(OCC(C)C)c1ccccc1C(=O)OCC(C)C
Properties
C16H22O4
Molar mass 278.348 g·mol−1
Appearance Colorless viscous liquid
Density 1.038 g/cm3
Melting point −37 °C (−35 °F; 236 K)
Boiling point 320 °C (608 °F; 593 K)
1 mg/L at 20 °C
log P 4.11
Vapor pressure 0.01 Pa at 20 °C
Hazards
GHS labelling:
GHS08: Health hazard
Danger
H360Df
P201, P202, P281, P308+P313, P405, P501
NFPA 704 (fire diamond)
NFPA 704 four-colored diamondHealth 2: Intense or continued but not chronic exposure could cause temporary incapacitation or possible residual injury. E.g. chloroformFlammability 1: Must be pre-heated before ignition can occur. Flash point over 93 °C (200 °F). E.g. canola oilInstability 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g. liquid nitrogenSpecial hazards (white): no code
2
1
0
Flash point 185 °C (365 °F; 458 K) c.c.
400 °C (752 °F; 673 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Diisobutyl phthalate (DIBP) is a

phthalate ester having the structural formula C6H4(COOCH2CH(CH3)2)2. It is formed by the esterification of isobutanol and phthalic anhydride. This and other phthalates are used as plasticizers due to their flexibility and durability. They are found in many industrial and personal products, such as lacquers, nail polish and cosmetics.[1] DIBP can be absorbed via oral ingestion and dermal exposure.[2] When it comes to excretion, DIBP is first converted into the hydrolytic monoester monoisobutyl phthalate (MIBP). The primary excretory route is urine, with biliary excretion being noted in minor amounts. DIBP has lower density and freezing point than the related compound dibutyl phthalate (DBP).[2]

History

In 1836 French chemist

Phthalates, including DIBP, were first introduced in the 1920s to make plastics more flexible, transparent and long-lived. They increased their popularity in 1931 when polyvinylchloride (PVC) became commercially available.[1] Due to the increase in human exposure to phthalates, in 1999 the European Union restricted the use of some of them in children's toys.[4]

Legislation

Date Action References
December 14, 2005 The European Union restricted phthalates from several children's toys. [4]
June 8, 2011 Guarantees the sale of electronic products free of phthalates. [5]
July 4, 2017 Included in the candidate list referred to as substances toxic for reproduction. [6]
November 23, 2021 DIBP is declared as an endocrine disrupting chemical. [7]
August 11, 2021 The European Parliament eliminates DIBP and other phthalates from sanitary products. [8]

Industry use

It is used as a plasticizer additive in a range of plastic and rubber materials.[2] It has low volatility, which makes it ideal for use in products that require long-lasting flexibility, e.g. automotive parts, wire and cable insulation, and flooring.[9] It is dense and water-insoluble.[10]

DIBP has been found to be relatively non-toxic, but high levels of exposure to the compound may cause irritation to the eyes, skin and respiratory tract.

phthalates, including DIBP. Therefore, several countries have restricted or even banned the use of certain phthalates in products.[9] DIBP has been detected in various environmental matrices, such as air, water, and sediment. DIBP is known to bioaccumulate in certain aquatic species[11]

Synthesis

DIBP is synthesized by a double

catalyst, such as sulfuric acid, sulfonated graphene, or iron(III) chloride
. Water is a byproduct.

Using sulfuric acid, the yield is 61% yield.[12]

Acid catalyzed reaction scheme of isobutanol and phthalic anhydride to form diisobutyl phthalate
Sulfuric acid catalyzed reaction of isobutanol and phthalic anhydride to form diisobutyl phthalate

Optimization

Sulfonated graphene is a heterogeneous catalyst that has several advantages over traditional liquid acids like sulfuric acid.[13] Sulfonated graphene can be easily separated from the reaction mixture by filtration and can be reused multiple times without reduction in activity.[14] Furthermore, sulfonated graphene is environmentally friendly, as it does not produce hazardous waste materials that are typically generated during the use of traditional liquid acid catalysts. This method has a 95% yield.[13]

Lewis acids, such as FeCl3, can also be used as the catalyst.[15] The Lewis acid catalysis process can be run at lower temperatures (50-100 °C), and gives a yield of 86%.[15]

Available forms

Diisobutyl phthalate is clear, colourless, oily liquid form with a mild odor.[16] It is insoluble in water but soluble in many organic solvents.[17]

DIBP can be sold as a pure substance or as a component of mixtures with other phthalate plasticizers or chemicals. Examples are dioctyl phthalate (DOP), diisononyl-phthalate (DINP), or bis(2-ethylhexyl) phthalate (DEHP).[18] It may be used as a component in formulations of several products including adhesives, paints, coatings and lubricants.[9] DIBP also may be present in consumer products such as toys, vinyl flooring, food packaging, and as a plasticizer or as a component of plastic formulations.[9] In many of these products DIBP is now prohibited to be used in formulations according to REACH.[18]

Environmental reactions

DIBP can undergo various reactions that may impact the environment. Examples include:

These reactions can impact the persistence, bioaccumulation, and toxicity in the environment and may have implications for human and ecosystem health.

Mechanisms of actions

PPARγ Pathway

The effects of DiBP exposure are mainly realized through its activation of

glucose metabolism through improving insulin sensitivity,[28][29] so binding of DiBP leads to altered leptin and insulin levels. DiBP also leads to a down-regulation of proteins involved in steroid production, resulting in higher levels of androgenic hormones.[25]

Cytokine-cytokine receptor pathway

Another type of pathway affected by DiBP exposure is the cytokine-cytokine receptor pathway. There are two pathways affected: the tumour necrosis factor receptor superfamily (TNFRSF) and the prolactin receptor pathway, both of which affect spermatogenesis.[25] In zebra fish, there are two types of TNFRSF: tnfrsf1a and tnfrsf1b, the latter of which is down-regulated by DiBP. Tnfrsf1b is involved in regeneration and tissue repair and its down-regulation has been shown to increase apoptosis of sperm cells.[30] Prolactin (PLR) on the other hand is up-regulated as a result of DiBP exposure.[25] Prolactin has many roles, including roles in cell regeneration and regulation of the male reproductive system.[31] High PLR concentrations as a result of phthalate exposure has been linked to reduced sperm concentrations in both adult men and zebra fish.[32][25]

Metabolism

The metabolism of DiBP to the simple monoester MiBP with possible further oxidation to either 2OH-MiBP or 3OH-MiBP. After oxidation a glucuronidation reaction can take place, resulting in MiBP-glucuronide.

Upon entering circulation DiBP is quickly metabolized and excreted through urine, with metabolites reaching peak concentrations 2–4 hours after administration.[33] The main metabolite of DiBP is mono-isobutyl phthalate (MiBP), which makes up 70% of the excretion products. MiBP can be oxidized to either 2OH-mono-isobutyl phthalate (2OH-MiBP) or 3OH-mono-isobutyl phthalate (3OH-MiBP), which make up 20% and 1% of the excretion products respectively. These reactions are likely catalyzed by cytochrome P450 in the liver.[34] The ratio between MiBP and the oxidized metabolites changes depending on the amount of time that has passed since exposure.[33] The ratio between MiBP and 2OH-MiBP and that between MiBP and 3OH-MiBP show a similar trend. With the ratios being high, around 20-30:1, shortly after exposure and dropping gradually as more time passes to rest around 2-5:1. Therefore, a high ratio of oxidized metabolites to the monoester metabolite suggests that there was recent exposure to DiBP, within a few hours of measuring, while a lower ratio suggests that there has been more time since exposure. In addition to oxidation, MiBP can also undergo a glucuronidation reaction, resulting in the metabolite MiBP-glucuronide.[35]

Toxicity

There's insufficient data to determine if DIBP is associated with acute dermal or inhalation toxicity, eye or dermal irritation, or sensitization. There is evidence on DIBP being a subchronic toxicant. Exposure to the compound can induce changes in body weight, liver weight, reproductive effects, and developmental effects like testicular weight, spermatogenesis, fetal body weight, anogenital distance in male and female rats, and testicular testosterone production, among others.[36]

Biomonitoring studies show that exposures to DIBP have grown recently, presumably as a result of DIBPs use as a substitute for other phthalates such as dibutyl phthalate (DBP) in plastics.[37][38] In the United States, for instance, the prevalence of MIBP detection in urine has risen from 72% of the general population in 2001–2002 to 96% in 2009–2010, according to data from the National Health and Nutrition Examination Survey (NHANES).[38]

The main issue with phthalate exposure is typically male reproductive toxicity, which is a risk that many phthalates share.[39]

Effect on animals

A study conducted on rats shows that high dosage of DIBP administered by

embryotoxicity and teratogenicity.[40] The growing male reproductive system was negatively impacted by DIBP, which is typical for phthalate esters. When phthalates are exposed in utero during the process of male sexual differentiation, a phenotype known as "phthalate syndrome" is created. This syndrome is characterized by underdevelopment of the male reproductive system, decreased anogenital distance (AGD), retention of the nipple in a female-like manner, and germ cell toxicity, among other things.[41][42][43] Therefore, these effects can be connected to decreased insulin-like-3 (INSL3) hormone, which controls transabdominal testicular descent, decreased androgen production in the testicles, which is essential for male sexual development, and disruption of seminiferous cord formation, Sertoli cells, and germ cell development via an unknown mode of action (MOA).[43][44][45]

Despite the limited studies in other species, research on zebrafish[46] shows that environmental exposure to DBP and DIBP can have serious consequences for fish offspring. As they go up the food chain and into polluted water, these phthalates can build up in aquatic organisms. Fish are susceptible to environmental toxins in their early lives, whether they are exposed to them directly or indirectly through their parents.

Species Exposure Route Dose Effect Reference
Sprague-Dawley Rats Oral (by gavage) 250, 500, 750, and 1000 mg/kg/day Pregnant females: Transient decrease in body weight gain, observed at 500 mg/kg and higher. Embryolethality and teratogenicity at 750 and 1000 mg/kg.

Male fetuses: Undescended testis at 500 mg/kg. The degree of transabdominal migration of testis in relation to the bladder were disturbed at 500 mg/kg and above.

[40]
Zebrafish Chemical exposure 10, 103 and 1038 μg L−1, (LC50) was 1037.7 μg L−1 Parental individual DIBP exposure disturbed key genes in circadian rhythm and phototransduction signal pathways, which could influence the eye development of F1 larvae. [46]
Wistar Rats Oral (by gavage) 600 mg/kg Disrupt fetal testicular development. AGD was reduced at GD 19 and GD 20/21 in males and increased in females exposed to DIBP. It also reduced bodyweights of male and female fetuses. [47]
Sprague-Dawley Rats Oral (by gavage) 100, 300, 600, and 900 mg/kg/day Reduced maternal body weight gain from 73 g in controls to 48 and 43 g in the 600 and 900 mg/kg/day dose groups, respectively. [48]
Wistar Rats Oral (by gavage) 600 mg/kg bw/day Reductions in fetal plasma leptin levels and in fetal insulin levels. Prenatal exposure disrupts fetal testosterone production in male rats by reducing the expression of several genes and proteins involved in steroidogenesis. In females, increases ovarian aromatase gene expression. DIBP also affected PPAR expression in the liver and testes. [49]
Sprague-Dawley Rats Oral 100, 300, 600, or 900 mg/kg/day Significantly reduced T production. Reduced fetal AGD, T levels, and Insl3. [50]
Sprague-Dawley Rats Oral (by gavage) 125, 250, 500, 625 mg/kg/day Doses ≥ 250 mg DIBP/(kg day) resulted in reduced AGD, and retained thoracic areolas/nipples at both early postnatal life, and adult necropsy. [51]

See also

References

  1. ^
    PMID 16466533
    .
  2. ^ a b c d "Diisobutyl phthalate". PubChem. National Center for Biotechnology Information, U.S. National Library of Medicine. p. 10. 6782. Retrieved 2023-03-17.
  3. ISSN 0035-2349
    .
  4. ^ a b "Directive 2005/84/EC of the European Parliament and of the Council". EUR-Lex - 32005L0084 - EN - EUR-Lex. (n.d.-b). 14 December 2005.
  5. ^ "Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the restriction of the use of certain hazardous substances in electrical and electronic equipment (recast) Text with EEA relevance". EUR-Lex - 32011L0065 - EN - EUR-Lex.
  6. ^ "Commission Implementing Decision (EU) 2017/1210 of 4 July 2017 on the identification of bis(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), benzyl butyl phthalate (BBP) and diisobutyl phthalate (DIBP) as substances of very high concern according to Article 57(f) of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (notified under document C(2017) 4462)". EUR-Lex - 32017D1210 - EN - EUR-Lex. (n.d.-b).
  7. ^ "Commission Regulation (EU) 2021/2045 of 23 November 2021 amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)". EUR-Lex - 32021R2045 - EN - EUR-Lex.
  8. ^ "Commission Delegated Directive (EU) 2021/1978 of 11 August 2021 amending, for the purposes of adapting to scientific and technical progress, Annex IV to Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for the use of bis(2-ethylhexyl) phthalate (DEHP), butyl benzyl phthalate (BBP), dibutyl phthalate (DBP) and diisobutyl phthalate (DIBP) in spare parts recovered from and used for the repair or refurbishment of medical devices". EUR-Lex - 32021L1978 - EN - EUR-Lex.
  9. ^ a b c d "Risk Evaluation for Di-isobutyl Phthalate - (1,2-Benzene- dicarboxylic acid, 1,2- bis-(2methylpropyl) ester)". Office of Chemical Safety and Pollution Prevention (OCSPP). U.S. Environmental Protection Agency. 2020-04-14. Retrieved 2023-03-17.
  10. ^ "Diisobutyl phthalate". ChEMBL. ELIXIR. CHEBI:79053.
  11. PMID 34482095
    .
  12. ISSN 0040-4039
    .
  13. ^
    ISSN 2046-2069
    .
  14. ISSN 0008-6223
    .
  15. ^
    S2CID 240582041
    .
  16. ^ "Metabocard for Diisobutyl phthalate". The Human Metabolome Database (HMDB). HMDB0013835. Retrieved 2023-03-17.
  17. ^ "DI-ISOBUTYL PHTHALATE | CAMEO Chemicals | NOAA". cameochemicals.noaa.gov. Retrieved 2023-03-17.
  18. ^ a b "Phthalates - ECHA". echa.europa.eu. Retrieved 2023-03-17.
  19. PMID 12943660
    .
  20. ^ "Diisobutyl_phthalate". Hazardous Substances Data Bank (HSDB). PubChem, U.S. National Library of Medicine. 5247. Retrieved 2023-03-18.
  21. PMID 31921775
    .
  22. PMID 19342169
    .
  23. ISSN 0964-8305
    .
  24. S2CID 245248168
    .
  25. ^
    S2CID 219959568
    .
  26. S2CID 2240461
    .
  27. PMID 15731109
    .
  28. PMID 14603033
    .
  29. PMID 12663460
    .
  30. S2CID 53112695
    .
  31. PMID 12087074
    .
  32. PMID 21440837
    .
  33. ^
    S2CID 253718517
    .
  34. PMID 32180766
    .
  35. PMID 32926938
    .
  36. ^ "Toxicity review of diisobutyl phthalate (DiBP)" (PDF). www.cpsc.gov. 2010. Archived from the original (PDF) on 20 April 2013. Retrieved 2023-03-17.
  37. PMID 17400024
    .
  38. ^
    PMID 24425099
    .
  39. PMID 30591249
    .
  40. ^
    PMID 16516415
    .
  41. ^ Foster PM, Gray Jr LE (2008). "Casarett and Doull's toxicology: The basic science of poisons". Toxicology: 761–806.
  42. S2CID 19276318
    .
  43. ^
    OCLC 586808833
    .
  44. PMID 22700540
    .
  45. PMID 19760678
    .
  46. ^
    S2CID 233447494
    .
  47. PMID 16458459
    .
  48. PMID 18411233
    .
  49. PMID 18602967
    .
  50. PMID 22112501
    .
  51. PMID 18706996
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diisobutyl_phthalate&oldid=1221886491"